Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Arsenic Trioxide Alone or With ATRA (Vesanoid) for Resistant Hematologic Malignancy

NCT00006220 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00006220
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006220 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Arsenic Trioxide Alone or With ATRA (Vesanoid) for Resistant Hematologic Malignancy
Lead sponsor
Washington University School of Medicine
Phase
Phase 1/2
Overall status
Terminated
Start date
June 30, 1999
Completion date
February 28, 2002
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma, multiple myeloma and plasma cell neoplasm, myelodysplastic syndromes